Oncogenic HRAS induces tumorigenesis in HNSCC following activation of ERK signaling leading to expression of a specific gene signature involving C-myc, BCL-2, BCL-XL and cyclin D1. Here, MYC is linked to head and neck squamous cell carcinoma.